Identification of a potent dual-function inhibitor for hIMPDH isoforms by computer-aided drug discovery approaches
Inosine monophosphate dehydrogenase (IMPDH) is a key enzyme in de novo biosynthesis of purine nucleotides. Due to this important role, it is a great target to drug discovery for a wide range of activities, especially immunosuppressant in heart and kidney transplantation. Both human IMPDH isoforms ar...
Main Authors: | Meysam Yazdani, Javad Zamani, Seyed Safa-Ali Fatemi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.977568/full |
Similar Items
-
c‐Myc–IMPDH1/2 axis promotes tumourigenesis by regulating GTP metabolic reprogramming
by: Qiang Zhang, et al.
Published: (2023-01-01) -
IMP/GTP balance modulates cytoophidium assembly and IMPDH activity
by: Gerson Dierley Keppeke, et al.
Published: (2018-06-01) -
Predictors of Serological Response to SARS-CoV-2 Vaccination in Kidney Transplant Patients: Baseline Characteristics, Immunosuppression, and the Role of IMPDH Monitoring
by: Lutz Liefeldt, et al.
Published: (2022-03-01) -
MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells
by: Jun-Zhang Zhao, et al.
Published: (2022-12-01) -
IMPDH inhibition activates TLR‐VCAM1 pathway and suppresses the development of MLL‐fusion leukemia
by: Xiaoxiao Liu, et al.
Published: (2023-01-01)